Oh Y - Search Results

1

Oh Y, Mao L. Oh Y, et al. Curr Opin Oncol. 1997 May;9(3):247-56. doi: 10.1097/00001622-199709030-00006. Curr Opin Oncol. 1997. PMID: 9229147 Review.

2

A novel C/T polymorphism in the core promoter of human de novo cytosine DNA methyltransferase 3B6 is associated with prognosis in head and neck cancer.

Wang L, Rodriguez M, Kim ES, Xu Y, Bekele N, El-Naggar AK, Hong WK, Mao L, Oh YW. Wang L, et al. Among authors: oh yw. Int J Oncol. 2004 Oct;25(4):993-9. Int J Oncol. 2004. PMID: 15375549

3

Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer.

Papadimitrakopoulou VA, Oh Y, El-Naggar A, Izzo J, Clayman G, Mao L. Papadimitrakopoulou VA, et al. Among authors: oh y. Clin Cancer Res. 1998 Mar;4(3):539-44. Clin Cancer Res. 1998. PMID: 9533520

4

Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines.

Kim SK, Su LK, Oh Y, Kemp BL, Hong WK, Mao L. Kim SK, et al. Among authors: oh y. Oncogene. 1998 Jan 8;16(1):89-93. doi: 10.1038/sj.onc.1201512. Oncogene. 1998. PMID: 9467947

5

TSG101 is not mutated in lung cancer but a shortened transcript is frequently expressed in small cell lung cancer.

Oh Y, Proctor ML, Fan YH, Su LK, Hong WK, Fong KM, Sekido YS, Gazdar AF, Minna JD, Mao L. Oh Y, et al. Oncogene. 1998 Sep 3;17(9):1141-8. doi: 10.1038/sj.onc.1202029. Oncogene. 1998. PMID: 9764824

6

Does marijuana or crack cocaine cause cancer?

Mao L, Oh Y. Mao L, et al. Among authors: oh y. J Natl Cancer Inst. 1998 Aug 19;90(16):1182-4. doi: 10.1093/jnci/90.16.1182. J Natl Cancer Inst. 1998. PMID: 9719073 No abstract available.

7

Current status of gene therapy for lung cancer and head and neck cancer.

Moon C, Oh Y, Roth JA. Moon C, et al. Among authors: oh y. Clin Cancer Res. 2003 Nov 1;9(14):5055-67. Clin Cancer Res. 2003. PMID: 14613982 Review.

8

Phase I trial of motexafin gadolinium in combination with docetaxel and cisplatin for the treatment of non-small cell lung cancer.

William WN Jr, Zinner RG, Karp DD, Oh YW, Glisson BS, Phan SC, Stewart DJ. William WN Jr, et al. J Thorac Oncol. 2007 Aug;2(8):745-50. doi: 10.1097/JTO.0b013e31811f4719. J Thorac Oncol. 2007. PMID: 17762342 Free article. Clinical Trial.

9

Enzastaurin, an oral serine/threonine kinase inhibitor, as second- or third-line therapy of non-small-cell lung cancer.

Oh Y, Herbst RS, Burris H, Cleverly A, Musib L, Lahn M, Bepler G. Oh Y, et al. J Clin Oncol. 2008 Mar 1;26(7):1135-41. doi: 10.1200/JCO.2007.14.3685. J Clin Oncol. 2008. PMID: 18309949 Clinical Trial.

10

Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases.

Oh Y, Taylor S, Bekele BN, Debnam JM, Allen PK, Suki D, Sawaya R, Komaki R, Stewart DJ, Karp DD. Oh Y, et al. Cancer. 2009 Jul 1;115(13):2930-8. doi: 10.1002/cncr.24333. Cancer. 2009. PMID: 19441110 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,685 results

Search Page

Filters